Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1

Clinical and Experimental Immunology

Volumn 173, Issue 1, 2013, Pages 84-91

  Ingram, R J ^a,f   Harris, A ^a   Ascough, S ^a   Metan, G ^e   Doganay, M ^e   Ballie, L ^b   Williamson, E D ^c   Dyson, H ^c   Robinson, J H ^d   Sriskandan, S ^a   Altmann, D M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e ERCIYES UNIVERSITY   (Turkey)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anthrax; ANTXR1; Monocyte; TEM 8; Toxin

Indexed keywords

ANTHRAX TOXIN; ANTHRAX TOXIN RECEPTOR 1; CELL SURFACE RECEPTOR; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; EXPOSURE; GENETIC VARIABILITY; HOST SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTE; MONOCYTE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANTHRAX; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; COHORT STUDIES; CONVALESCENCE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREAT BRITAIN; HUMANS; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; SKIN DISEASES, BACTERIAL; TURKEY; VACCINATION;

EID: 84878800244     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12090     Document Type: Article

References (30)

1. Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 2004; 7:19-24. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15036135 (accessed 11 April 2012).
2. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC. Crystal structure of the anthrax toxin protective antigen. Nature 1997; 385:833-838. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9039918 (accessed 2 March 2012).
3. Lacy DB, Wigelsworth DJ, Scobie HM, Young JAT, Collier RJ. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc Natl Acad Sci USA 2004; 101:6367-6372. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=404051&tool=pmcentrez&rendertype=abstract (accessed 11 April 2012).
4. Santelli E, Bankston LA, Leppla SH, Liddington RC. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature 2004; 430:905-908. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15243628 (accessed 11 April 2012).
5. Wigelsworth DJ, Krantz BA, Christensen KA, Lacy DB, Juris SJ, Collier RJ. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem 2004; 279:23349-23356. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15044490 (accessed 2 April 2012).
6. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. Identification of the cellular receptor for anthrax toxin. Nature 2001; 414:225-229. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11700562 (accessed 4 March 2012).
7. Scobie HM, Rainey GJA, Bradley KA, Young JAT. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci USA 2003; 100:5170-5174. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154317&tool=pmcentrez&rendertype=abstract (accessed 11 April 2012).
8. Martchenko M, Jeong S-Y, Cohen SN. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci USA 2010; 107:15583-15588. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2932583&tool=pmcentrez&rendertype=abstract (accessed 6 November 2012).
9. Bonuccelli G, Sotgia F, Frank PG etal. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am J Physiol Cell Physiol 2005; 288:C1402-1410. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15689409 (accessed 11 April 2012).
10. Xu Q, Hesek ED, Zeng M. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore. Microb Pathog 2007; 43:37-45. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1973154&tool=pmcentrez&rendertype=abstract (accessed 11 April 2012).
11. Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, Terman BI. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 2005; 305:133-144. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15777794 (accessed 11 April 2012).
12. Werner E, Kowalczyk AP, Faundez V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 2006; 281:23227-23236. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16762926 (accessed 11 April 2012).
13. Young JJ, Bromberg-White JL, Zylstra C etal. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog 2007; 3:e27. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?%20artid=1808072&tool=pmcentrez&rendertype=abstract (accessed 11 April 2012).
14. Banks DJ, Barnajian M, Maldonado-Arocho FJ, Sanchez AM, Bradley KA. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol 2005; 7:1173-1185. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16008584 (accessed 11 April 2012).
15. Salles II, Voth DE, Ward SC etal. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1. Cell Microbiol 2006; 8:1272-1281. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16882031 (accessed 11 April 2012).
16. Cote CK, DiMezzo TL, Banks DJ, France B, Bradley KA, Welkos SL. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microbes Infect 2008; 10:613-619. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18467145 (accessed 11 April 2012).
17. Fukao T. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect Dis 2004; 4:166-170. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14998502 (accessed 11 April 2012).
18. Joshi SK, Lang GA, Larabee JL etal. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy. PLoS Pathog 2009; 5:e1000588. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2742733&tool=pmcentrez&rendertype=abstract (accessed 18 March 2012).
19. Maldonado-Arocho FJ, Fulcher JA, Lee B, Bradley KA. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol Microbiol 2006; 61:324-337. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16856939 (accessed 11 April 2012).
20. Ingram RJ, Chu KK, Metan G etal. An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans. Infect Immun 2010; 78:2353; author reply 2353-4. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863510&tool=pmcentrez&rendertype=abstract (accessed 6 April 2012).
21. Ingram RJ, Metan G, Maillere B etal. Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes. J Immunol 2010; 184:3814-3821. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20208010 (accessed 22 March 2012).
22. Martchenko M, Candille SI, Tang H, Cohen SN. Human genetic variation altering anthrax toxin sensitivity. Proc Natl Acad Sci USA 2012; 109:2972-2977. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3286947&tool=pmcentrez&rendertype=abstract (accessed 11 April 2012).
23. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health 2010; 3:98-105. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20869669 (accessed 11 April 2012).
24. Popov SG, Villasmil R, Bernardi J etal. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem Biophys Res Commun 2002; 293:349-355. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12054607 (accessed 8 November 2012).
25. Muehlbauer SM, Evering TH, Bonuccelli G etal. Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle 2007; 6:758-766. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17374996 (accessed 8 November 2012).
26. Terra JK, Cote CK, France B etal. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol 2010; 184:17-20. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2811128&tool=pmcentrez&rendertype=abstract (accessed 8 November 2012).
27. Scobie HM, Young JAT. Interactions between anthrax toxin receptors and protective antigen. Curr Opin Microbiol 2005; 8:106-112. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15694864 (accessed 9 November 2012).
28. Fu S, Tong X, Cai C etal. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. PloS ONE 2010; 5:e11203. Available at: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0011203#pone.0011203-Rainey1 (accessed 9 November 2012).
29. Cai C, Che J, Xu L etal. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. PloS ONE 2011; 6:e20646. Available at: http://dx.plos.org/10.1371/journal.pone.0020646 (accessed 9 November 2012).
30. Glomski IJ, Corre J-P, Mock M, Goossens PL. Cutting edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol 2007; 178:2646-2650. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17312104 (accessed 11 April 2012).